Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198523 | 12519852 | 3 | F | 20160715 | 20160630 | 20160722 | EXP | CA-PFIZER INC-2016313545 | PFIZER | 45.00 | YR | F | Y | 0.00000 | 20160722 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125198523 | 12519852 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 25 MG, WEEKLY | 11719 | 25 | MG | /wk | |||||||
| 125198523 | 12519852 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1500MG (500MG 3 TABS), TWICE A DAY | N | 7073 | 1500 | MG | BID | ||||||
| 125198523 | 12519852 | 3 | SS | IMURAN | AZATHIOPRINE | 1 | 100MG EVERY MORNING AND 50MG EVERY EVENING | 0 | 150 | MG | |||||||||
| 125198523 | 12519852 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MG, 2X/DAY | U | 0 | 200 | MG | BID | |||||||
| 125198523 | 12519852 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, 1X/DAY | U | 0 | 20 | MG | QD | |||||||
| 125198523 | 12519852 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, EVERY 2 WEEKS, MORE THAN 3 MONTHS | N | 0 | 40 | MG | |||||||
| 125198523 | 12519852 | 7 | C | NAPROSYN | NAPROXEN | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125198523 | 12519852 | 1 | Rheumatoid arthritis |
| 125198523 | 12519852 | 2 | Rheumatoid arthritis |
| 125198523 | 12519852 | 3 | Rheumatoid arthritis |
| 125198523 | 12519852 | 4 | Rheumatoid arthritis |
| 125198523 | 12519852 | 5 | Rheumatoid arthritis |
| 125198523 | 12519852 | 6 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125198523 | 12519852 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125198523 | 12519852 | Condition aggravated | |
| 125198523 | 12519852 | Drug ineffective | |
| 125198523 | 12519852 | Insomnia | |
| 125198523 | 12519852 | Multiple sclerosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125198523 | 12519852 | 6 | 201202 | 0 |